Evaluation of Dementia Rating Scales in Parkinson's Disease Dementia

被引:12
|
作者
Harvey, Philip D. [1 ]
Ferris, Steven H. [2 ,3 ]
Cummings, Jeffrey L. [4 ]
Wesnes, Keith A. [5 ]
Hsu, Chuanchieh [6 ]
Lane, Roger M. [6 ]
Tekin, Sibel [6 ]
机构
[1] Emory Univ, Sch Med, Atlanta, GA 30322 USA
[2] NYU, Sch Med, Rush Alzheimers Dis Ctr, New York, NY USA
[3] Nathan Kline Inst Orange Burg, New York, NY USA
[4] Univ Calif Los Angeles, Mary S Easton Ctr Alzheimers Dis Res, Los Angeles, CA USA
[5] Cognit Drug Res Ltd, Goring On Thames, England
[6] Novartis Pharmaceut, E Hanover, NJ USA
关键词
dementia assessment scales; Parkinson's disease dementia; validity; reliability; MONTREAL COGNITIVE ASSESSMENT; ALZHEIMERS-DISEASE; CLINICAL-DIAGNOSIS; RIVASTIGMINE; IMPAIRMENT; INVENTORY;
D O I
10.1177/1533317509333904
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Disease-specific assessments are not currently available for patients with Parkinson's disease dementia (PDD). This study evaluated the criterion-related validity and test-retest reliability of the Alzheimer's Disease Assessment scale cognitive subscale (ADAS-cog) in terms of sensitivity for differentiation between mild and moderate severity impairment in PDD. Six other dementia rating scales and cognitive tests were also examined. A total of 113 patients with PDD or Alzheimer disease were recruited into this 4-week, multicenter study, segregated into 2 severity groups based on Mini-Mental State Examination (MMSE) score. Mean ADAS-cog scores showed a statistically significant separation between mild and moderate severity patients in both dementias (P < .001). For the ADAS-cog, test-retest Spearman correlation coefficients were significant for each dementia type and severity. This study demonstrated the criterion-related validity and test-retest reliability for ADAS-cog in patients with PDD and strong correlations with MMSE. This supports the validity of previous results obtained with these measures in studies of patients with PDD.
引用
收藏
页码:142 / 148
页数:7
相关论文
共 50 条
  • [41] Addenbrooke's cognitive examination, mattis dementia rating scale and frontal assessment battery for diagnosing dementia in Parkinson's disease
    Kovacs, N.
    Kaszas, B.
    Balas, I.
    Aschermann, Z.
    Kerekes, Z.
    Nagy, F.
    Komoly, S.
    Karadi, K.
    JOURNAL OF NEUROLOGY, 2011, 258 : 186 - 187
  • [42] Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
    Jellinger, Kurt A.
    Korczyn, Amos D.
    BMC MEDICINE, 2018, 16
  • [43] Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?
    Kurt A. Jellinger
    Amos D. Korczyn
    BMC Medicine, 16
  • [44] Family history of dementia: Dementia with Lewy bodies and dementia in Parkinson's disease
    Papapetropoulos, S
    Lieberman, A
    Gonzalez, J
    Singer, C
    Laufer, DZ
    Mash, DC
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2006, 18 (01) : 113 - 116
  • [45] Rating scales for dyskinesias in Parkinson's disease
    Goetz, CG
    MOVEMENT DISORDERS, 1999, 14 : 48 - 53
  • [46] Rating scales and questionnaires in Parkinson's disease
    Mauduit, N
    Schück, S
    Allain, H
    Chaperon, J
    REVUE NEUROLOGIQUE, 2000, 156 : 63 - 69
  • [47] Evaluation of the Dementia Apraxia Test in Parkinson's Disease Patients
    Renftle, Daniela
    Becker, Sara
    Brockmann, Kathrin
    Gasser, Thomas
    Michaelis, Katja
    Solbrig, Susanne
    Sulzer, Patricia
    Johnen, Andreas
    Liepelt-Scarfone, Inga
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2022, 51 (03) : 271 - 278
  • [49] Economic evaluation of rivastigmine in patients with Parkinson's disease dementia
    Willan, AR
    Goeree, R
    Pullenayegum, EM
    McBurney, C
    Blackhouse, G
    PHARMACOECONOMICS, 2006, 24 (01) : 93 - 106
  • [50] Treatment of Dementia with Lewy Bodies and Parkinson’s Disease Dementia
    Clive Ballard
    Zunera Kahn
    Anne Corbett
    Drugs & Aging, 2011, 28 : 769 - 777